|
JPS5328935B2
(OSRAM)
|
1972-01-20 |
1978-08-17 |
|
|
|
JPS56104333A
(en)
*
|
1980-01-23 |
1981-08-20 |
Fuji Photo Film Co Ltd |
Color photographic sensitive material
|
|
DE3445669A1
(de)
|
1984-12-14 |
1986-06-19 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
JPS6232459A
(ja)
|
1985-08-05 |
1987-02-12 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS6238463A
(ja)
|
1985-08-14 |
1987-02-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−感光材料の画像形成方法
|
|
JPH067250B2
(ja)
|
1985-10-18 |
1994-01-26 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料
|
|
JPS6292939A
(ja)
|
1985-10-19 |
1987-04-28 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
JPH0756566B2
(ja)
|
1985-11-06 |
1995-06-14 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62129853A
(ja)
|
1985-11-30 |
1987-06-12 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
|
JPS62153953A
(ja)
|
1985-12-27 |
1987-07-08 |
Fuji Photo Film Co Ltd |
カラ−写真感光材料
|
|
JPS62173466A
(ja)
|
1986-01-28 |
1987-07-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
JPS62222251A
(ja)
|
1986-02-17 |
1987-09-30 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
|
JPS62257158A
(ja)
|
1986-04-30 |
1987-11-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料
|
|
EP0254280B1
(en)
|
1986-07-22 |
1993-12-29 |
Fuji Photo Film Co., Ltd. |
Method for processing silver halide color photographic material
|
|
DE3803775A1
(de)
|
1988-02-09 |
1989-08-17 |
Boehringer Mannheim Gmbh |
Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
|
|
JPH02234158A
(ja)
|
1989-03-07 |
1990-09-17 |
Fuji Photo Film Co Ltd |
カラー感光材料
|
|
JPH02264946A
(ja)
|
1989-04-05 |
1990-10-29 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
JPH02267548A
(ja)
|
1989-04-10 |
1990-11-01 |
Fuji Photo Film Co Ltd |
画像形成法
|
|
DE3925584A1
(de)
|
1989-08-02 |
1991-02-07 |
Boehringer Mannheim Gmbh |
Neue n-(dimethyloxophosphinylmethyl-)-lactame, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
DE4027592A1
(de)
|
1990-08-31 |
1992-03-05 |
Beiersdorf Ag |
Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
|
|
JPH04315148A
(ja)
|
1991-04-15 |
1992-11-06 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
|
GB9205702D0
(en)
|
1992-03-16 |
1992-04-29 |
Fujisawa Pharmaceutical Co |
A new use of a quinazoline derivative
|
|
DE69310098T2
(de)
|
1992-10-15 |
1997-07-31 |
Fuji Photo Film Co., Ltd., Minami-Ashigara, Kanagawa |
Verarbeitungsverfahren für farbphotographisches Silberhalogenidmaterial
|
|
ES2186720T3
(es)
|
1994-05-27 |
2003-05-16 |
Merck & Co Inc |
Composiciones para inhibir la reabsorcion osea mediada por osteoclastos.
|
|
US5756502A
(en)
|
1994-08-08 |
1998-05-26 |
Warner-Lambert Company |
Quinazolinone derivatives as cholyecystokinin (CCK) ligands
|
|
TW381092B
(en)
*
|
1995-07-07 |
2000-02-01 |
Otsuka Pharma Co Ltd |
Novel benzimidazole derivatives for use in treating arteriosclerotic diseases
|
|
US5747235A
(en)
|
1996-01-26 |
1998-05-05 |
Eastman Kodak Company |
Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
|
|
JP2000505471A
(ja)
|
1996-02-28 |
2000-05-09 |
メルク エンド カンパニー インコーポレーテッド |
フィブリノーゲン受容体拮抗物質
|
|
US5780480A
(en)
|
1996-02-28 |
1998-07-14 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
JP2002511054A
(ja)
|
1996-12-30 |
2002-04-09 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル蛋白トランスフェラーゼ阻害薬
|
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
|
WO1999031086A1
(en)
|
1997-12-12 |
1999-06-24 |
Smithkline Beecham Plc |
Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
|
|
HU227711B1
(en)
|
1997-12-22 |
2011-12-28 |
Bayer Healthcare Llc |
Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas and pharmaceutical compositions containing them
|
|
DE19839499A1
(de)
|
1998-08-29 |
2000-03-02 |
Merck Patent Gmbh |
2-Oxo-2H-chinolinderivate
|
|
AU2001234690A1
(en)
|
2000-02-01 |
2001-08-14 |
Cor Therapeutics, Inc. |
2-(1h)-quinolone and 2-(1h)-quinoxalone inhibitors of factor xa
|
|
JP2002341484A
(ja)
|
2001-03-12 |
2002-11-27 |
Fuji Photo Film Co Ltd |
熱現像感光材料
|
|
JP2002296731A
(ja)
|
2001-03-30 |
2002-10-09 |
Fuji Photo Film Co Ltd |
熱現像カラー画像記録材料
|
|
JP2004532856A
(ja)
*
|
2001-04-30 |
2004-10-28 |
藤沢薬品工業株式会社 |
アポリポタンパク質ｂ阻害剤としてのビアリールカルボキサミド化合物
|
|
BR0209687A
(pt)
|
2001-05-15 |
2004-09-14 |
Du Pont |
Método de controle de doenças vegetais, composto e composição
|
|
JP2003321472A
(ja)
|
2002-02-26 |
2003-11-11 |
Takeda Chem Ind Ltd |
Ｇｒｋ阻害剤
|
|
EP1388342A1
(en)
|
2002-08-07 |
2004-02-11 |
Aventis Pharma Deutschland GmbH |
Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
|
|
BR0313743A
(pt)
|
2002-08-23 |
2005-07-05 |
Chiron Corp |
Benzimidazol quinolinonas e usos destas
|
|
US7825132B2
(en)
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
|
AU2003272347A1
(en)
|
2002-09-17 |
2004-04-08 |
Merck And Co., Inc. |
Removal of aldehyde impurity by reactive polystyrene resin
|
|
EP1572212A2
(en)
|
2002-12-11 |
2005-09-14 |
7TM Pharma A/S |
Quinoline compounds for use in mch receptor related disorders
|
|
US20040142950A1
(en)
|
2003-01-17 |
2004-07-22 |
Bunker Amy Mae |
Amide and ester matrix metalloproteinase inhibitors
|
|
US7205318B2
(en)
|
2003-03-18 |
2007-04-17 |
Bristol-Myers Squibb Company |
Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
|
|
WO2004110350A2
(en)
|
2003-05-14 |
2004-12-23 |
Torreypines Therapeutics, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
|
WO2004113330A1
(en)
|
2003-05-19 |
2004-12-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
KR101167573B1
(ko)
|
2003-11-07 |
2012-07-30 |
노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 |
개선된 약학적 성질을 갖는 퀴놀리논 화합물의 약학적으로허용가능한 염
|
|
WO2005087742A1
(en)
|
2004-03-08 |
2005-09-22 |
Exelixis, Inc. |
Metabolic kinase modulators and methods of use as pesticides
|
|
WO2005094805A1
(ja)
|
2004-04-01 |
2005-10-13 |
Institute Of Medicinal Molecular Design. Inc. |
イミン誘導体及びアミド誘導体
|
|
JP2008501689A
(ja)
|
2004-06-03 |
2008-01-24 |
ブランデイス ユニヴァーシティー |
シンコナアルカロイドを基本構造とする二官能触媒を用いた不斉マイケル付加およびアルドール付加反応
|
|
GB0416730D0
(en)
|
2004-07-27 |
2004-09-01 |
Novartis Ag |
Organic compounds
|
|
EP1655295A1
(en)
*
|
2004-11-03 |
2006-05-10 |
Schering Aktiengesellschaft |
Anthranilamide pyridinureas as VEGF receptor kinase inhibitors
|
|
UY29198A1
(es)
|
2004-11-09 |
2006-05-31 |
Cancer Rec Tech Ltd |
Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones
|
|
US20060281763A1
(en)
|
2005-03-25 |
2006-12-14 |
Axon Jonathan R |
Carboxamide inhibitors of TGFbeta
|
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
|
GB0509224D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of intracellular enzymatic activity
|
|
WO2006130437A2
(en)
|
2005-05-27 |
2006-12-07 |
Brandeis University |
Asymmetric carbon-carbon-bond-forming reactions catalyzed by bifunctional cinchona alkaloids
|
|
US20090240055A1
(en)
|
2005-09-23 |
2009-09-24 |
Krepski Larry R |
Method for 1H-Imidazo[4,5-C] Pyridines and Analogs Thereof
|
|
BRPI0709555B1
(pt)
|
2006-02-16 |
2015-11-03 |
Syngenta Ltd |
compostos pesticidas contendo uma estrutura de bisamida bicíclica, composição pesticida, e método para controlar pestes.
|
|
GB0605689D0
(en)
|
2006-03-21 |
2006-05-03 |
Novartis Ag |
Organic compounds
|
|
US7601716B2
(en)
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
|
JP2009537632A
(ja)
|
2006-05-19 |
2009-10-29 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
過剰増殖性障害および血管新生障害の処置に有用なピリドンカルボキサミド誘導体
|
|
WO2008029152A2
(en)
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
|
CA2665438C
(en)
|
2006-10-04 |
2014-12-02 |
Tibotec Pharmaceuticals Ltd. |
Carboxamide 4-[(4-pyridyl)amino]pyrimidines useful as hcv inhibitors
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
AU2008219166B2
(en)
|
2007-02-16 |
2013-05-16 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and their use as c-Met inhibitors
|
|
CA2680177A1
(en)
*
|
2007-03-07 |
2008-09-12 |
Alantos Pharmaceuticals Holding, Inc. |
Metalloprotease inhibitors containing a heterocyclic moiety
|
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
|
JP2008280341A
(ja)
|
2007-04-12 |
2008-11-20 |
Sumitomo Chemical Co Ltd |
ヒドラジド化合物およびその防除用途
|
|
EP2147310A4
(en)
|
2007-04-27 |
2010-09-08 |
Univ Rochester |
COMPOSITIONS AND METHODS OF INHIBITING G-PROTEIN SIGNALING
|
|
EP2008658A1
(en)
|
2007-06-28 |
2008-12-31 |
Bayer Schering Pharma Aktiengesellschaft |
Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
|
|
RU2543620C2
(ru)
|
2007-09-17 |
2015-03-10 |
Эббви Бахамаз Лтд. |
Производные урацила или тимина для лечения гепатита с
|
|
EA201001847A1
(ru)
|
2008-06-11 |
2011-08-30 |
Айрм Ллк |
Соединения и композиции, применяемые для лечения малярии
|
|
US20100068204A1
(en)
|
2008-09-12 |
2010-03-18 |
Wyeth |
4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
|
|
US20100267752A1
(en)
|
2008-10-15 |
2010-10-21 |
Gilead Palo Alto, Inc. |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
|
|
AU2009331659B2
(en)
|
2008-12-23 |
2015-09-03 |
F. Hoffmann-La Roche Ag |
Dihydropyridone amides as P2X7 modulators
|
|
WO2010101949A1
(en)
|
2009-03-02 |
2010-09-10 |
Sirtris Pharmaceuticals, Inc. |
8-substituted quinolines and related analogs as sirtuin modulators
|
|
US8278302B2
(en)
*
|
2009-04-08 |
2012-10-02 |
Boehringer Ingelheim International Gmbh |
Substituted piperidines as CCR3 antagonists
|
|
US8362249B2
(en)
|
2009-04-27 |
2013-01-29 |
Boehringer Ingelheim International Gmbh |
CXCR3 receptor antagonists
|
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
|
ES2652304T3
(es)
*
|
2009-11-05 |
2018-02-01 |
Glaxosmithkline Llc |
Compuesto de benzodiacepina novedoso
|
|
US20130109672A1
(en)
|
2010-04-29 |
2013-05-02 |
The United States Of America,As Represented By The Secretary, Department Of Health And Human Service |
Activators of human pyruvate kinase
|
|
ES2715611T3
(es)
|
2010-05-17 |
2019-06-05 |
Incozen Therapeutics Pvt Ltd |
Compuestos novedosos de 3H-imidazo[4,5-b]piridina-3,5-disustituida y 3H-[1,2,3]triazolo[4,5-b]piridina 3,5-disustituida como moduladores de proteína cinasas
|
|
WO2011156632A2
(en)
|
2010-06-09 |
2011-12-15 |
Georgetown University |
Compositions and methods of treatment for tumors in the nervous system
|
|
WO2012020820A1
(ja)
|
2010-08-11 |
2012-02-16 |
大正製薬株式会社 |
ヘテロアリール－ピラゾール誘導体
|
|
AR084070A1
(es)
*
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
PH12013501489A1
(en)
|
2010-12-17 |
2013-08-28 |
Hoffmann La Roche |
Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
|
|
TW201309639A
(zh)
|
2011-02-17 |
2013-03-01 |
Lg Life Sciences Ltd |
作為ｇｐｒ１１９促效劑之肟衍生物
|
|
WO2012125668A1
(en)
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
|
|
GB201106750D0
(en)
*
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
JP5742439B2
(ja)
|
2011-05-02 |
2015-07-01 |
信越化学工業株式会社 |
蛍光性化合物及び蛍光性樹脂組成物
|
|
DK2713722T3
(en)
|
2011-05-31 |
2017-07-03 |
Celgene Int Ii Sarl |
Newly known GLP-1 receptor stabilizers and modulators
|
|
CN102887895B
(zh)
|
2011-07-22 |
2016-08-24 |
山东轩竹医药科技有限公司 |
吡啶并嘧啶类mTOR抑制剂
|
|
US20140315881A1
(en)
|
2011-07-29 |
2014-10-23 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
|
WO2013027168A1
(en)
*
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
EP2899183B1
(en)
*
|
2011-10-14 |
2018-09-19 |
Bristol-Myers Squibb Company |
Substituted Tetrahydroisoquinoline Compounds as Factor Xia Inhibitors
|
|
WO2013063462A2
(en)
|
2011-10-26 |
2013-05-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method of treating hcv infection with a small molecule chk2 inhibitor
|
|
US9701658B2
(en)
|
2012-04-25 |
2017-07-11 |
Raqualia Pharma Inc. |
Amide derivatives as TTX-S blockers
|
|
WO2014034719A1
(ja)
|
2012-08-29 |
2014-03-06 |
興和株式会社 |
Ｔｌｒ阻害作用を有するキノリン誘導体
|
|
WO2014095775A1
(de)
|
2012-12-20 |
2014-06-26 |
Bayer Pharma Aktiengesellschaft |
Bet-proteininhibitorische dihydrochinoxalinone
|
|
JP2016504990A
(ja)
|
2012-12-20 |
2016-02-18 |
バイエル ファーマ アクチエンゲゼルシャフト |
Ｂｅｔタンパク質抑制性ジヒドロピリドピラジノン
|